Navigation Links
Titanium dioxide nanoreactor
Date:2/21/2013

This press release is available in German.

Now, Dr. Katja Henzler and a team of chemists at the Helmholtz Centre Berlin have developed a synthesis to produce nanoparticles at room temperature in a polymer network. Their analysis, conducted at BESSY II, Berlin's synchrotron radiation source, has revealed the crystalline structure of the nanoparticles. This represents a major step forward in the usage of polymeric nanoreactors since, until recently, the nanoparticles had to be thoroughly heated to get them to crystallize. The last synthesis step can be spared due to the special environment inside the PNIPAM network.

The Henzler team's polymeric nanoreactors consist of a polystyrene core surrounded by a network of PNIPAM chains. A titanium compound was added to an ethanolic solution of the polymer colloids, which did trigger the formation of small titanium dioxide particles within the PNIPAM network. The BESSY II experiments showed that the chemists were able to control the speed of these processes while at the same time affecting the quality of the nanocrystals that had formed.

Using the novel combination of x-ray microscopy and spectroscopy (NEXAFS-TXM, U41-SGM) at BESSY II, Henzler and the microscopy team were able to show that the nanoparticles are homogeneously distributed over the polymeric nanoreactors. The researchers examined their samples in a cryogenic aqueous environment, which prevents artifact formation due to sample drying. Their analysis showed that the nanoparticles have a crystalline structure. "The nanocrystals have a tetragonal anatase structure and this crystalline structure is a key to their catalytic performance.

Additionally, our new analytic method allows us to control the quality of the synthesized particles so that we can optimize them for relevant applications," says Katja Henzler.


'/>"/>

Contact: Katja Henzler
katja.henzler@helmholtz-berlin.de
49-030-806-243-198
Helmholtz Association of German Research Centres
Source:Eurekalert  

Page: 1

Related biology technology :

1. New Data Shows GeNO LLC Nitric Oxide Delivery System Provided Nitric Oxide With Low Levels of Nitrogen Dioxide for Heart Transplant Patient Evaluation
2. From lemons to lemonade: Using carbon dioxide to make carbon nitride
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Titanium dioxide nanoreactor
(Date:1/13/2017)... ... January 13, 2017 , ... ... containing an organic compound called fulvic acid that farms, greenhouses and hydroponics operations ... grow cannabis are among the fastest growing segments of customers using this high ...
(Date:1/12/2017)... ... January 12, 2017 , ... ... IS A SUCCESS , VTI, Vertebral Technologies, Inc., announces the successful outcome ... expandable device. Since September 2016, VTI (Vertebral Technologies, Inc.) has partnered with ...
(Date:1/12/2017)... ... ... Huffman Engineering, Inc. , a leader in control systems integration, today announced ... as a chemical engineer. In his new role, Beck will use his extensive ... manufacturing and water/wastewater industries. , Prior to joining Huffman Engineering, Beck served for nine ...
(Date:1/12/2017)... 2017   Protein Sciences Corporation , a ... Flublok Influenza Vaccine ®, announced today that its ... safety results and induced strong neutralizing antibodies against ... is expected to advance into human clinical trials ... Institute of Technology in Immunobiologicals of the Oswaldo ...
Breaking Biology Technology:
(Date:1/4/2017)... , Jan. 4, 2017  CES 2017 – ... biometric sensor technology, today announced the launch of ... sensor systems, the highly-accurate biometric sensor modules that ... biometric technology, experience and expertise. The two new ... designed specifically for hearables, and Benchmark BW2.0, a ...
(Date:12/22/2016)... 2016 SuperCom (NASDAQ:   ... the e-Government, Public Safety, HealthCare, and Finance sectors announced today that ... selected to implement and deploy a community-based supportive services program to ... , further expanding its presence in the state. ... This new program, which is ...
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL anunció ... acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar a ... con múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el ... de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos ...
Breaking Biology News(10 mins):